Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2014
11/04/2014US8877706 Maytansinoid derivatives
11/04/2014US8877705 Biomaterial for the controlled delivery of ingredients
11/04/2014US8877494 Human corneal epithelial cell line PTA-120527
11/04/2014US8877473 Formulations of recombinant furin
11/04/2014US8877321 Sizing-adhesive composition
11/04/2014US8877252 Polymer-based sustained release device
11/04/2014US8877251 Powder compositions for inhalation
11/04/2014US8877243 Cross-linked polysaccharide composition
11/04/2014US8877234 Preservatives
11/04/2014US8877232 Bioactive compounds protection method and compositions containing the same
11/04/2014US8877231 Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease
11/04/2014US8877226 Dexamethasone formulations in a biodegradable material
11/04/2014US8877225 Controlled release copolymer formulation with improved release kinetics
11/04/2014US8877207 Nanoparticles of cerium oxide targeted to an amyloid-beta antigen of Alzheimer's disease and associated methods
11/04/2014US8877205 Yeast-based therapeutic for chronic hepatitis B infection
11/04/2014US8877183 Methods for treatment of ocular diseases
11/04/2014US8877175 Long lasting drug formulations
11/04/2014US8877172 Zwitterionic polymer bioconjugates and related methods
11/04/2014US8877171 Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis
11/04/2014US8877168 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
11/04/2014US8877164 Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
11/04/2014US8877162 Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery
11/04/2014US8877158 Targeting agent to newly formed blood vessels
10/2014
10/30/2014US20140323690 Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
10/30/2014US20140323688 Chemical Reagents for the Activation of Polysaccharides in the Preparation of Conjugate Vaccines
10/30/2014US20140323592 Use of isosorbide diesters as thickeners
10/30/2014US20140323589 Method for the preparation of composite silica alcogels, aerogels and xerogels, apparatus for carrying out the method continuously, and novel composite silica alcogels, aerogels and xerogels
10/30/2014US20140323578 Polymeric colorant compositions and methods of use
10/30/2014US20140323566 Self-magnetic metal-salen complex compound
10/30/2014US20140323565 Oligomer-Calcimimetic Conjugates and Related Compunds
10/30/2014US20140323550 Intestinal fibrosis treatment agent
10/30/2014US20140323548 Novel amino alcohol cationic lipids for oligonucleotide delivery
10/30/2014US20140323529 Oligomer-calcium channel blocker conjugates
10/30/2014US20140323517 Compositions and methods for injection of a biodegradable polymer-based delivery system
10/30/2014US20140323514 Multi-arm polymer prodrugs
10/30/2014US20140323513 Chemotherapeutic Compositions and Methods for Treating Human Gliomas
10/30/2014US20140323512 Acrylic Polymer Formulations
10/30/2014US20140323495 Stabilized Amorphous Forms of Imatinib Mesylate
10/30/2014US20140323472 Methods and compositions for the delivery of a therapeutic agent
10/30/2014US20140323454 Anaesthetic composition
10/30/2014US20140323445 Salicylic Acid Gel
10/30/2014US20140323434 Lipid conjugates in the treatment of chronic rfhinosinusitis
10/30/2014US20140323415 Organic compounds
10/30/2014US20140323407 Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
10/30/2014US20140323402 Protein Carrier-Linked Prodrugs
10/30/2014US20140323392 Methods and compositions related to inhibition of viral entry
10/30/2014US20140323389 Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation
10/30/2014US20140322791 Process to prepare a stable thrombin composition
10/30/2014US20140322349 Microbicidal composition comprising hydrogen peroxide and aminocarboxylic acids
10/30/2014US20140322338 Flurbiprofen formulations
10/30/2014US20140322333 Chelated nanoceria for the treatment of oxidative stress
10/30/2014US20140322327 Drug delivery system for sustained delivery of bioactive agents
10/30/2014US20140322325 Pharmaceutical compositions providing enhanced drug concentrations
10/30/2014US20140322317 Controlled release compositions
10/30/2014US20140322314 Omega-3 Fatty Acid Formulations for Use as Pharmaceutical Treatment
10/30/2014US20140322309 Alpha-aminoamidine polymers and uses thereof
10/30/2014US20140322306 Medical Use
10/30/2014US20140322300 Patch
10/30/2014US20140322299 Controlled Release of Active Using pH
10/30/2014US20140322298 Stable transdermal amphetamine compositions and methods of manufacture
10/30/2014US20140322297 Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
10/30/2014US20140322287 Bioactive coatings
10/30/2014US20140322282 Microcrystalline Cellulose Compositions
10/30/2014US20140322258 Polysaccharide-protein conjugate vaccines
10/30/2014US20140322248 Dual Specific Immunotoxin for Brain Tumor Therapy
10/30/2014US20140322247 Cell proliferation inhibitors and conjugates thereof
10/30/2014US20140322246 IGE ANTI-HMW-MAA Antibody
10/30/2014US20140322233 Anti-gcc antibody molecules and related compositions and methods
10/30/2014US20140322221 Multivalent antibodies and uses therefor
10/30/2014US20140322220 Anti-FGFR2 Antibodies and Uses Thereof
10/30/2014US20140322206 Method for treating atrophic age related macular degeneration
10/30/2014US20140322203 Formulations with reduced oxidation
10/30/2014US20140322160 Method and composition for altering a b cell mediated pathology
10/30/2014US20140322143 Water-absorbent adhesive compositions and associated methods of manufacture and use
10/30/2014US20140322134 Treatment and Imaging Methods Using Antibodies to Aminophospholipids
10/30/2014US20140322129 Anti-b7-h4 antibodies and immunoconjugates
10/28/2014US8871911 Compositions and methods for the diagnosis and treatment of tumor
10/28/2014US8871908 Antibodies specific for Trop-2 and their uses
10/28/2014US8871818 Gastrointestinal absorption enhancer mediated by proton-coupled transporter and its preparing method
10/28/2014US8871816 Methods for producing vaccine adjuvants
10/28/2014US8871813 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
10/28/2014US8871809 Diclofenac topical formulation
10/28/2014US8871795 Pharmaceutical oral telmisartan solution
10/28/2014US8871791 Narcotic emulsion formulations for treatment of cancer pain
10/28/2014US8871780 Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, method of making and use thereof
10/28/2014US8871763 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies
10/28/2014US8871744 Compounds and methods for selectively targeting tumor-associated mucins
10/28/2014US8871743 Bacterial cellulose composite with capsules embedded therein and preparation thereof
10/28/2014US8871732 Immunostimulatory sequence oligonucleotides and methods of using the same
10/28/2014US8871713 Formulations of growth hormone releasing factor (GRF) molecules with improved stability
10/28/2014US8871509 Nanoparticle-based gene delivery systems
10/28/2014US8871281 Treatment of oral pharyngeal dysphagia
10/28/2014US8871272 Layered nanoparticles
10/28/2014US8871270 Tablet excipient
10/28/2014US8871269 Method for the preparation of controlled release formulations
10/28/2014US8871267 Protein matrix materials, devices and methods of making and using thereof
10/28/2014US8871266 Probiotic storage and delivery
10/28/2014US8871263 Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder
10/28/2014US8871260 Methods and compositions for muscular and neuromuscular diseases
10/28/2014US8871259 Techniques and systems for treatment of neuropathic pain and other indications
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 1712